Prelude Capital Management’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,977
Closed -$209K 1613
2025
Q4
$209K Buy
+3,977
New +$201K 0.02% 1038
2022
Q3
Sell
-2,061
Closed -$24K 1937
2022
Q2
$24K Sell
2,061
-2,045
-50% -$27.3K ﹤0.01% 1527
2022
Q1
$70K Sell
4,106
-23,268
-85% -$633K ﹤0.01% 1462
2021
Q4
$1.17M Buy
+27,374
New +$1.33M 0.03% 531
2017
Q4
Sell
-420
Closed -$44K 1741
2017
Q3
$44K Buy
+420
New +$42.9K ﹤0.01% 1138
2017
Q2
Sell
-124
Closed -$13K 1877
2017
Q1
$13K Buy
+124
New +$12.7K ﹤0.01% 1333
2016
Q4
Sell
-64
Closed -$6K 1792
2016
Q3
$6K Buy
+64
New +$6.43K ﹤0.01% 1478

Other funds holding VEON

Prelude Capital Management's VEON Position: Q1 2026 in Review

Prelude Capital Management sold out of VEON (VEON) in Q1 2026, closing a stake of 3,977 shares — an estimated $209K sold.

Prelude Capital Management first reported a position in VEON in Q3 2016 and held it in 7 quarters. The position peaked at $1.17M in Q4 2021. 101 funds tracked by Wall St. Rank hold VEON as of Q1 2026.

  • Prelude Capital Management reported no remaining VEON position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 3,977 VEON shares in Q1 2026, an estimated $209K.
  • Prelude Capital Management first reported a position in VEON in Q3 2016 and held it in 7 quarters.
  • Prelude Capital Management's VEON position peaked at $1.17M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held VEON as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.